|
Having trouble seeing this email? View it in your browser instead. |
|
|
|
|
Cambridge Research Biochemicals is dedicated to providing the highest quality service in custom-made peptides and antibodies. With 30 years of experience and being the second oldest peptide manufacturer in the world; Cambridge Research Biochemicals is wrapped in history. Based in the North-East of England, CRB has long standing roots and strong associations with Cambridge.
|
Why Cambridge Research Biochemicals?
|
|
|
|
In 1980 Cambridge Research Biochemicals established itself as the second oldest peptide company in the world in Cambridge UK by entrepreneur Ken Liddle and a group of leading peptide research scientists from the Medical Research Council (MRC-LMB) making chemically synthesised peptides.
A decade later CRB expanded into custom made antibody production, was bought out by ICI and moved to two sites in the north. The Billingham, Teesside site primarily produced radiolabelled peptides and organics where the Northwich, Cheshire site took charge of peptides and antibody products for research.
In the year 2000 a management buy-out of CRB took place retaining the original company name. Cambridge Research Biochemicals gained ISO 9001:2000 Quality Management System Accreditation and moved to new premises at Belasis Hall Technology Park, Billingham.
|
|
|
Thirty years on CRB revisits its past re-establishing custom monoclonal antibody production through an alliance with Babraham Bioscience Technologies, Cambridge and is also accredited ISO9001:2008 Quality Management System. In sponsoring Campod (Cambridge Fund for the Prevention of Disease) and becoming a full member of One Nucleus, CRB is proud to support Cambridge enterprises.
|
|
|
This year in 2010 CRB has recently won the preferred supplier Research Councils United Kingdom (RCUK) tender agreement for peptide and antibody supply and regularly visits the MRC-LMB building and other foundations around Cambridge to promote this successful arrangement.
|
|
|
|
|
|
|
As a key supplier of custom synthesised peptides and custom generated polyclonal and monoclonal antibodies. This new two-year contract will enable CRB to build on its existing relationship with the Medical Research Council and other UK Research Councils. CRB is delighted to have been appointed as preferred supplier and aims to expand production and client-handling teams to ensure that the high technical and service standards required by the Research Councils, is continuously achieved.
|
|
|
Richard Fowles, Category Manager for RCUK SSC Ltd commented that "CRB demonstrated a very high level of professionalism within their tender submission which demonstrated their strong commitment to the quality and ethical standards required by the Research Councils. We are delighted to welcome them as a supply partner and look forward to building a mutually beneficial relationship with them."
|
|
|
|
|
|
|
|
This agreement is one of a series that has enabled CRB to grow strongly over the last two years by increasing market share in existing territories and penetrating new overseas markets with Europe and North America. In 2009 CRB was invited as peptide experts and named as partners in the 6 million euro BIOSCENT project, part of the European Seventh Framework Programme for peptide research and technological development.
|
|
|
|
|
|
The Cambridge Cell Biology Seminar Series is a series of lectures which has a showcase of guest speakers talking about their specialist research. Held in the Wellcome Trust/MRC Building on the Addenbrooke's site in Cambridge the seminar series has an audience drawn from across Cambridge including MRC/LMB and CIMR which is a clinical school institute based in the Wellcome Trust/MRC building. The series is organized by Paul Luzio who is the Director of CIMR. Many of the seminar audience are interested in membrane traffic and this has been reflected in the speaker program over the past few years. Earlier this year the series covered topics such as:
 |
Mechanisms of endosome traffic in neurons |
 |
Peptide-dependent Trafficking of MHC Class I and the members of its Peptide Loading Complex |
 |
Rival forces of phosphorylation in nucleocytoplasmic transport and heterodimerization of hypoxia-inducible transcription factor HIF-1 |
 |
Mechanisms of ER to Golgi transport: liminal calcium, vesicle coats, SNAREs, and neutrodegeneration. |
|
|
|
Cambridge Research Biochemicals is a major sponsor of this series to promote the new preferred supplier agreement and exhibits each month. CRB is also looking to sponsor other series for the year 2011 and is open to all suggestions. Please forward any ideas to enquiries@crbdiscovery.com. You can visit our stand on the following dates:
|
|
6th Dec
|
|
10th Jan
|
|
7th Feb
|
|
7th Mar
|
|
4th April
|
|
16th May
|
|
20th June
|
|
18th July
|
|
|
|
|
|
|
|
View our full range of products
Visit our website to view our full range of products, we offer products for the following: |
|
|
|
|
|
|
|
|